Table 4.

Background of patients stratified by administration of remdesivir (with or without remdesivir) after matching

	Without remdesivir		With remdesivir		p valuea
	n	%	n	%
Age
< 60	90	30.6	30	30.6	1.000
60 s	51	17.3	17	17.3
≥ 70	153	52.0	51	52.0
Gender
Male	210	71.7	67	68.4	0.524
Female	83	28.3	31	31.6
Primary disease
Chronic glomerulonephritis	40	15.1	20	22.5	0.372
Diabetes mellitus	149	56.2	43	48.3
Nephrosclerosis	39	14.7	12	13.5
Others	37	14.0	14	15.7
Duration of dialysis
< 1 year	37	12.9	14	14.4	0.754
1 to < 5 years	100	34.8	31	32.0
5 to < 10 years	72	25.1	30	30.9
10 to < 15 years	42	14.6	13	13.4
≥ 15 years	36	12.5	9	9.3
Complication
Hypertension
No	156	55.1	42	42.9	0.046
Yes	127	44.9	56	57.1
Diabetes mellitus
No	124	43.5	46	46.9	0.558
Yes	161	56.5	52	53.1
Cardiovascular disease
No	156	56.5	49	51.6	0.406
Yes	120	43.5	46	48.4
Chronic respiratory disease
No	249	89.6	83	87.4	0.571
Yes	29	10.4	12	12.6
Peripheral arterial disease
No	230	84.9	75	78.9	0.201
Yes	41	15.1	20	21.1
Malignancy
No	234	84.2	83	87.4	0.509
Yes	44	15.8	12	12.6
Number of complication
0	38	13.1	10	10.2	0.778
1	84	29.1	29	29.6
≥ 2	167	57.8	59	60.2
Oxygenation
No	69	23.5	23	23.5	1.000
Yes	159	54.1	53	54.1
Ventilator or ECMO	66	22.4	22	22.4

ECMO extracorporeal membrane oxygenation

^aFisher’s exact test